These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10340292)

  • 1. Delusions, superstitious conditioning and chaotic dopamine neurodynamics.
    Shaner A
    Med Hypotheses; 1999 Feb; 52(2):119-23. PubMed ID: 10340292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced locomotor activity in rats with excitotoxic lesions of the entorhinal cortex, a neurodevelopmental animal model of schizophrenia: behavioral and in vivo microdialysis studies.
    Sumiyoshi T; Tsunoda M; Uehara T; Tanaka K; Itoh H; Sumiyoshi C; Kurachi M
    Neurosci Lett; 2004 Jul; 364(2):124-9. PubMed ID: 15196692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia as a dynamical disease.
    an der Heiden U
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S36-42. PubMed ID: 16508894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estradiol inhibits dopamine mediated behavior in rats--an animal model of sex-specific differences in schizophrenia].
    Gattaz WF; Behrens S; De Vry J; Häfner H
    Fortschr Neurol Psychiatr; 1992 Jan; 60(1):8-16. PubMed ID: 1312053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensory gating deficits, pattern completion, and disturbed fronto-limbic balance, a model for description of hallucinations and delusions in schizophrenia.
    Javanbakht A
    Med Hypotheses; 2006; 67(5):1173-84. PubMed ID: 16824690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From superstitious behavior to delusional thinking: the role of the hippocampus in misattributions of causality.
    Brugger P; Dowdy MA; Graves RE
    Med Hypotheses; 1994 Dec; 43(6):397-402. PubMed ID: 7739412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of dopamine in conditioning and latent inhibition: what, when, where and how?
    Young AM; Moran PM; Joseph MH
    Neurosci Biobehav Rev; 2005; 29(6):963-76. PubMed ID: 16045987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amphetamine-induced sensitized state as a model of schizophrenia.
    Featherstone RE; Kapur S; Fletcher PJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Nov; 31(8):1556-71. PubMed ID: 17884274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.
    Rünkorg K; Värv S; Matsui T; Kõks S; Vasar E
    Neurosci Lett; 2006 Oct; 406(1-2):17-22. PubMed ID: 16916582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.
    Sotty F; Montezinho LP; Steiniger-Brach B; Nielsen J
    J Neurochem; 2009 May; 109(3):766-75. PubMed ID: 19236563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated exposure to amphetamine disrupts dopaminergic modulation of excitatory synaptic plasticity and neurotransmission in nucleus accumbens.
    Li Y; Kauer JA
    Synapse; 2004 Jan; 51(1):1-10. PubMed ID: 14579420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient high-frequency firing in a coupled-oscillator model of the mesencephalic dopaminergic neuron.
    Kuznetsov AS; Kopell NJ; Wilson CJ
    J Neurophysiol; 2006 Feb; 95(2):932-47. PubMed ID: 16207783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal phencyclidine treatment selectively attenuates mesolimbic dopamine function in adult rats as revealed by methamphetamine-induced behavior and c-fos mRNA expression in the brain.
    Semba J; Tanaka N; Wakuta M; Suhara T
    Synapse; 2001 Apr; 40(1):11-8. PubMed ID: 11170217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic dysfunction in schizophrenia: salience attribution revisited.
    Heinz A; Schlagenhauf F
    Schizophr Bull; 2010 May; 36(3):472-85. PubMed ID: 20453041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory, knowledge and delusions.
    McKenna PJ
    Br J Psychiatry Suppl; 1991 Nov; (14):36-41. PubMed ID: 1840777
    [No Abstract]   [Full Text] [Related]  

  • 18. Amphetamine sensitization in rats as an animal model of schizophrenia.
    Peleg-Raibstein D; Knuesel I; Feldon J
    Behav Brain Res; 2008 Aug; 191(2):190-201. PubMed ID: 18486243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual-incentive motivation and paced sexual behavior in female rats after treatment with drugs modifying dopaminergic neurotransmission.
    Ellingsen E; Agmo A
    Pharmacol Biochem Behav; 2004 Mar; 77(3):431-45. PubMed ID: 15006453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic possibilities of cysteamine in the treatment of schizophrenia.
    Pae CU; Lee C; Paik IH
    Med Hypotheses; 2007; 69(1):199-202. PubMed ID: 17166669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.